"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
| Descriptor ID |
D015415
|
| MeSH Number(s) |
D23.101
|
| Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 7 | 9 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 10 | 11 |
| 2000 | 1 | 11 | 12 |
| 2001 | 1 | 14 | 15 |
| 2002 | 3 | 22 | 25 |
| 2003 | 2 | 26 | 28 |
| 2004 | 3 | 22 | 25 |
| 2005 | 1 | 42 | 43 |
| 2006 | 3 | 42 | 45 |
| 2007 | 5 | 48 | 53 |
| 2008 | 12 | 45 | 57 |
| 2009 | 6 | 54 | 60 |
| 2010 | 11 | 67 | 78 |
| 2011 | 12 | 92 | 104 |
| 2012 | 9 | 84 | 93 |
| 2013 | 20 | 92 | 112 |
| 2014 | 19 | 113 | 132 |
| 2015 | 16 | 123 | 139 |
| 2016 | 26 | 119 | 145 |
| 2017 | 17 | 130 | 147 |
| 2018 | 24 | 130 | 154 |
| 2019 | 14 | 139 | 153 |
| 2020 | 20 | 135 | 155 |
| 2021 | 16 | 129 | 145 |
| 2022 | 4 | 103 | 107 |
| 2023 | 5 | 92 | 97 |
| 2024 | 39 | 67 | 106 |
| 2025 | 11 | 99 | 110 |
| 2026 | 13 | 81 | 94 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies. Eur J Clin Invest. 2026 Oct; 56(10):e70256.
-
Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts. Heart. 2026 Sep 24; 112(20):1153-1162.
-
Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention. Methodist Debakey Cardiovasc J. 2026; 22(4):28-39.
-
Analytical Performance Evaluation of the Cardiac Troponin T High Sensitivity Gen 6 Assay. J Appl Lab Med. 2026 Sep 03; 11(5):1009-1025.
-
C-Reactive Protein as a Biomarker of Inflammation and Graft Injury After Kidney and Heart Allo- and Xenotransplantation Into Non-Human Primates. Xenotransplantation. 2026 Sep-Oct; 33(5):e70168.
-
Do Not Throw Out the Radiographs! Radiographic Disease Severity as a Prognostic Biomarker for the Onset of Frequent Knee Pain. J Rheumatol. 2026 09 01; 53(9):1025-1027.
-
Metabolites Associated With Long-Term Risk of Peripheral Artery Disease: The ARIC Study. Arterioscler Thromb Vasc Biol. 2026 Oct; 46(10):e324549.
-
Development and Optimization of an LC-MS/MS Method for Quantification of Phosphatidylethanol in Human Whole Blood. J Mass Spectrom. 2026 Aug; 61(8):e70083.
-
Donor-Derived Cell-Free DNA in Stable Pediatric Kidney Transplant Recipients: Influence of Donor Obesity and Recipient Size. Pediatr Transplant. 2026 Aug; 30(8):e70416.
-
Comprehensive Evaluation of Atherosclerotic Cardiovascular Disease Risk Predictors Across the Pooled Cohort Equations, Predicting Risk of Cardiovascular Disease Events, and an Expanded Model. J Am Heart Assoc. 2026 08 04; 15(15):e049726.